You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API PRIMIDONE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing PRIMIDONE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Bausch Health US LLC MYSOLINE primidone 66490-690 CELLULOSE, MICROCRYSTALLINE
Bausch Health US LLC MYSOLINE primidone 66490-690 LACTOSE MONOHYDRATE
Bausch Health US LLC MYSOLINE primidone 66490-690 MAGNESIUM STEARATE
Bausch Health US LLC MYSOLINE primidone 66490-690 METHYLCELLULOSE
Bausch Health US LLC MYSOLINE primidone 66490-690 SODIUM LAURYL SULFATE
Bausch Health US LLC MYSOLINE primidone 66490-690 SODIUM STARCH GLYCOLATE TYPE A POTATO
Bausch Health US LLC MYSOLINE primidone 66490-690 TALC
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing PRIMIDONE

Company Ingredient NDC Excipient
Lannett Company Inc primidone 0527-1301 ACACIA
Lannett Company Inc primidone 0527-1301 LACTOSE MONOHYDRATE
Lannett Company Inc primidone 0527-1301 MAGNESIUM STEARATE
Lannett Company Inc primidone 0527-1301 METHYLCELLULOSE
Lannett Company Inc primidone 0527-1301 SODIUM STARCH GLYCOLATE TYPE A POTATO
Actavis Pharma Inc primidone 0591-5321 CELLULOSE, MICROCRYSTALLINE
Actavis Pharma Inc primidone 0591-5321 DOCUSATE SODIUM
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for PRIMIDONE

Excipient focus: ACACIA

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: DOCUSATE SODIUM

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYLCELLULOSE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

PRIMIDONE drug variants not containing MICROCRYSTALLINE CELLULOSE 101

Company Ingredient NDC
Lannett Company Inc primidone 0527-1301
Actavis Pharma Inc primidone 0591-5321
Par Pharmaceutical primidone 0603-5371
NCS HealthCare of KY Inc dba Vangard Labs primidone 0615-2521
NCS HealthCare of KY Inc dba Vangard Labs primidone 0615-7738
Major Pharmaceuticals primidone 0904-5559
Marlex Pharmaceuticals Inc primidone 10135-540
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POVIDONE

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

PRIMIDONE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A

Company Ingredient NDC
Lannett Company Inc primidone 0527-1301
Actavis Pharma Inc primidone 0591-5321
Par Pharmaceutical primidone 0603-5371
NCS HealthCare of KY Inc dba Vangard Labs primidone 0615-2521
NCS HealthCare of KY Inc dba Vangard Labs primidone 0615-7738
Major Pharmaceuticals primidone 0904-5559
Marlex Pharmaceuticals Inc primidone 10135-540
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

PRIMIDONE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Lannett Company Inc primidone 0527-1301
Actavis Pharma Inc primidone 0591-5321
Par Pharmaceutical primidone 0603-5371
NCS HealthCare of KY Inc dba Vangard Labs primidone 0615-2521
NCS HealthCare of KY Inc dba Vangard Labs primidone 0615-7738
Major Pharmaceuticals primidone 0904-5559
Marlex Pharmaceuticals Inc primidone 10135-540
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group